Skip to main content

Day: February 20, 2024

Global Organ Preservation Market to Surpass USD 410.24 Million by 2030 Driven by Increasing Aging Population

SkyQuest projects that the global organ preservation market will attain a value of USD 410.24 million by 2030, with a CAGR of 6.8% during the forecast period (2024-2030). One of the leading causes of death cases in the ICU is multiorgan failure, usually caused by sepsis. It is estimated that approximately 20% of individuals with sepsis have acute respiratory failure and 26–50% have acute renal impairment (Society of Critical Care Medicine) in the global organ preservation market. Acute renal impairment is common in the elderly due to an age-related decrease in renal blood flow and glomerular filtration rate. Diabetes predisposes people to both of these diseases and multiple organ failures. Older patients are more likely to develop diseases such as tuberculosis and liver disease, which may require organ transplantation. Westford, USA, Feb....

Continue reading

Right on Brands Announces 11th Store Opening

DALLAS, Feb. 20, 2024 (GLOBE NEWSWIRE) — Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC company and a leading developer of a diverse range of hemp-based and THCA products, announced today that it is opening its 11th licensed store at 1102 Ranch Road Suite 218, Forney Texas. Forney, which is in Kaufman County, is the fastest-growing county in the country. The population of the county to the east grew 18% from 2016 to 2021, according to census estimates. The 800-square-mile county is seeing more than 30,000 new homes being built or in early development stages in its six biggest cities. Calculating for 4 people per household, the county is preparing for a population increase of about 120,000 more people in the next 18 months. The company is excited to open the first Endo Dispensary in Kaufman County. We have several...

Continue reading

Interim Management Report first half year 2023/24

Interim Management Report covering H1 2023/24 The Board of Directors of Rovsing A/S has today approved the Interim Management Report for the first half-year (1 July 2023 – 31 December 2023) of the financial year 2023/24. H1 highlightsIn the first half year of the financial year 2023/24, the revenue amounted to DKK 17,9 million (H1 2022/23: DKK 13,4 million) or an increase of 33,6% (DKK 4,5 million).EBITDA amounted to DKK 1,2 million (H1 2022/23: DKK 0,5 million) or an increase of DKK 0,7 million.The order backlog at 31 December 2023 remains at a high level of DKK 54,5 million (H1 2022/23 DKK 43,9 million), with an order intake in H1 of 2023/24 of DKK 4,9 million (H1 2022/23 DKK 24,9 million). The current order backlog is diverse, ranging across several different missions and customers in both institutional and commercial space. A...

Continue reading

Titan NRG (TTNN) Announces Record Profits for Third Quarter Fiscal 2023

TUCSON, AZ, Feb. 20, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Titan NRG, Inc. (OTCPK: TTNN) (the “Company”), a leader in integrated downstream energy and transportation holding company, today announced results for its third quarter fiscal 2023 ended December 31, 2023. While much of the country experienced unseasonably warm weather during the October-through-December period, Titan NRG showcased its resiliency, efficiency, and growth trajectory to generate a net profit in quarter 3 of Fiscal 2023. Highlights from the quarterly report include:$2.3 million in revenue $1.04 million in gross profit $130,624 in net profit $6.3 million in capital assets (before depreciation) $905,520 cash on hand as of December 31, 2023Operational highlights for the quarter include:15 million plus gallons of liquefied petroleum gas transported Over...

Continue reading

BIO-key Receives $1.5M Pre-Paid, Two-Year Software Subscription Order for its Biometric Identification Platform

Over 25 Million Clients Authenticate with BIO-key HOLMDEL, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software infrastructure featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that a long-term financial services customer has executed a two-year, pre-paid $1.5 million agreement for the ongoing use and expanded deployment of BIO-key’s biometric customer identification technology. The agreement follows continued strong growth in client enrollments by the customer over eight years since its first deployment. The BIO-key system streamlines and enhances security for the client identification process for over 25 million clients and contemplates...

Continue reading

Ascot Provides Construction Update on the Premier Gold Project

Figure 1Visible gold in quartz vein found in ore drive 6 at Big MissouriFigure 2TSF overview looking southFigure 3TSF South and Southeast dams completeFigure 4WTP commissioningFigure 5WTP MBBR systemFigure 6Mill piping over 90% completeFigure 7Premier underground portal overheadFigure 8Premier underground portal front viewFigure 9Mill area overviewVANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) —  Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to provide a construction update on the Company’s Premier Gold Project (“PGP” or the “Project”), located on Nisga’a Nation Treaty Lands in the prolific Golden Triangle of northwestern British Columbia. Project construction was 86% complete as of December 31, 2023...

Continue reading

HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot

VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN “HYTN or The Company“), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“Nano Shot”) to the key markets of British Columbia and Alberta. Following its initial success in Ontario, Canada’s largest market, this move represents a significant stride in the company’s national distribution goals. “The enthusiasm from the western provinces for Nano Shot has been remarkable,” stated HYTN Chief Executive Officer, Elliot McKerr. “Introducing our distinctive Nano Shot product line to these vibrant markets highlights HYTN’s dedication to innovation and quality. We are committed...

Continue reading

PharmAla Data to be Published in ACS Chemical Neuroscience

Scientific Journal Article follows notable IP updates, including publication of key PCT Patent Application, presentation at International Society for Research into Psychedelics Conference VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased that data from its computational Drug Discovery program, in conjunction with the University of Waterloo (laboratory of Dr. James Gauld) and made possible by funding from MITACS, will be published in the scientific journal ACS Chemical Neuroscience this week. The article “Exploring Structure-Activity Relationships in Phenethylamines:...

Continue reading

Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028

CUPERTINO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, today announced an updated Aemetis Five Year Plan (the “2024 Plan”) that projects the company will generate $1.95 billion in revenues and $645 million of adjusted EBITDA in year 2028.  The 2024 Plan states revenues are expected to grow at a compound annual growth rate of 38%, and adjusted EBITDA is expected to grow at a projected compound annual growth rate of 83% for the years 2024 to 2028. A presentation summarizing the updated Five Year Plan is available for review on the Aemetis website at www.aemetis.com/Five-Year-Plan. In the Aemetis 2024 Five Year Plan, the Company’s revenue and adjusted EBITDA growth is expected from 75 dairies...

Continue reading

Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day. The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/7cha7jae. To listen to the conference call on your telephone, participants may register for the call here. While it is not required, it is recommended you join 10 minutes prior to the event start. About Neuronetics Neuronetics, Inc....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.